Teva Pharmaceutical Industries Ltd. (TEVA)
36.76
+0.40
(+1.10%)
USD |
NYSE |
Sep 08, 16:00
36.76
0.00 (0.00%)
Pre-Market: 07:48
Teva Pharmaceutical Industries Price to Book Value : 5.524 for Sept. 8, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 5.524 |
| September 04, 2026 | 5.464 |
| September 03, 2026 | 5.503 |
| September 02, 2026 | 5.634 |
| September 01, 2026 | 5.438 |
| August 31, 2026 | 5.417 |
| August 28, 2026 | 5.476 |
| August 27, 2026 | 5.653 |
| August 26, 2026 | 5.698 |
| August 25, 2026 | 5.725 |
| August 24, 2026 | 5.549 |
| August 21, 2026 | 5.611 |
| August 20, 2026 | 5.531 |
| August 19, 2026 | 5.630 |
| August 18, 2026 | 5.497 |
| August 17, 2026 | 5.479 |
| August 14, 2026 | 5.525 |
| August 13, 2026 | 5.488 |
| August 12, 2026 | 5.521 |
| August 11, 2026 | 5.482 |
| August 10, 2026 | 5.431 |
| August 07, 2026 | 5.313 |
| August 06, 2026 | 5.231 |
| August 05, 2026 | 5.217 |
| August 04, 2026 | 5.174 |
| Date | Value |
|---|---|
| August 03, 2026 | 5.178 |
| July 31, 2026 | 5.261 |
| July 30, 2026 | 5.321 |
| July 29, 2026 | 5.216 |
| July 28, 2026 | 4.759 |
| July 27, 2026 | 4.670 |
| July 24, 2026 | 4.630 |
| July 23, 2026 | 4.685 |
| July 22, 2026 | 4.530 |
| July 21, 2026 | 4.711 |
| July 20, 2026 | 4.658 |
| July 17, 2026 | 4.813 |
| July 16, 2026 | 4.842 |
| July 15, 2026 | 4.742 |
| July 14, 2026 | 4.781 |
| July 13, 2026 | 4.836 |
| July 10, 2026 | 4.951 |
| July 09, 2026 | 4.974 |
| July 08, 2026 | 4.995 |
| July 07, 2026 | 5.207 |
| July 06, 2026 | 5.303 |
| July 02, 2026 | 5.205 |
| July 01, 2026 | 5.025 |
| June 30, 2026 | 5.091 |
| June 29, 2026 | 4.712 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Eli Lilly & Co. | 31.23 |
| Bristol Myers Squibb Co. | 5.922 |
| RedHill Biopharma Ltd. | -- |
| Johnson & Johnson | 7.627 |
| MediWound Ltd. | 4.868 |
Price to Book Value Related Metrics
| PE Ratio | 61.81 |
| PS Ratio | 2.465 |
| Price to Free Cash Flow | 29.29 |
| Price | 36.76 |
| Earnings Yield | 1.62% |
| Market Cap | 42.83B |
| Operating PE Ratio | 13.12 |
| Normalized PE Ratio | 23.16 |